Stockreport

UPDATE 2-Astellas Pharma keeps profit forecast as prostate cancer drug sales rise [Reuters]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF UPDATE 2-Astellas Pharma keeps profit forecast as prostate cancer drug sales rise (Updates shares, adds results of Daiichi Sankyo, Eisai in 10th, 11th paragraphs) By Roc [Read more]